Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7a pseudogene 38 (RPL7AP38) is classified as a pseudogene—a DNA sequence similar to the protein-coding gene RPL7A (which encodes the 60S ribosomal protein L7a, a component of the large ribosomal subunit). RPL7AP38 does not encode a functional ribosomal protein; instead, it represents a nonfunctional, processed copy of RPL7A scattered in the genome. Pseudogenes like RPL7AP38 do not have a recognized direct role in molecular biology, drug targeting, or disease association and are not considered therapeutic targets. Their primary relevance is as genomic elements that can contribute to genetic studies, gene regulation research, or serve as evolutionary markers. If you are interested in the functional, protein-coding ribosomal protein, the correct entry would be "Ribosomal protein L7a" (RPL7A), not the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 38 (RPL7AP38).